Align Technology, US0162551016

Align Technology stock trades well below analyst targets after recent 3.2 percent slide

Published on 09/09/2026 at 21:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Align Technology stock closed at USD 153.52 on Nasdaq on September 8, 2026, down 3.2 percent and near the lower end of its 52-week range. Analysts still see upside, with a consensus price target of USD 206.36 implying roughly 34 percent potential.

Architekturrender moderner Medtech-Campus in der Wüste Arizonas
Align Technology Inc. Architekturrender moderner Medizintechnik-Campus in Arizona Firmensitz digitale Kieferorthopädie NASDAQ US0162551016, Illustration mit AI erstellt.

Align Technology stock (ISIN US0162551016) closed at USD 153.52 on the Nasdaq on September 8, 2026, marking a 3.2 percent decline from the previous session and underscoring a weak short-term tone for the clear-aligner specialist.

Stock trades near lower end of 52-week band

According to GuruFocus, Align Technology shares fell 3.2 percent to USD 153.52 on September 8, 2026, trading within a documented 52-week range of USD 122.00 to USD 200.44.

This latest close places the stock much closer to the 52-week low of USD 122.00 than to the high of USD 200.44, highlighting that investors value the company well below the highs seen earlier in the year.

Market data compiled by MarketBeat shows Align Technology trading around USD 153.49 on Nasdaq in recent sessions, with a market capitalization of USD 10.99 billion as of early September 2026.

Valuation gap versus intrinsic value models

In its assessment dated September 8, 2026, GuruFocus estimates a GF Value of USD 224.44 for Align Technology, compared with the trading price of USD 153.52, implying the shares are 31.6 percent below this intrinsic value model.

The same analysis assigns Align Technology a GF Score of 85 out of 100, with sub-scores of 9 out of 10 for profitability and 7 out of 10 for financial strength, while valuation receives a weaker 4 out of 10 rating.

For investors, the numerical gap between the GF Value estimate of USD 224.44 and the actual market price near USD 153.52 is a central point of discussion, suggesting potential upside if the company can maintain its profitability metrics and growth profile.

Analysts maintain Moderate Buy stance with upside

According to data aggregated by MarketBeat as of September 9, 2026, Align Technology carries a consensus rating of Moderate Buy, based on one strong buy, eight buy and six hold recommendations.

The same overview reports a consensus analyst price target of USD 206.36, representing about 34.4 percent upside from a reference price of USD 153.49, which is close to the recent closing level of USD 153.52.

That combination of a Moderate Buy rating and a double-digit percentage upside target indicates that, despite the recent 3.2 percent decline, many covering analysts continue to see room for valuation normalization if execution and demand trends remain intact.

Upcoming conference appearance keeps investor focus on strategy

As Benzinga reported on September 8, 2026, Align Technology is scheduled to present at the Baird 2026 Global Healthcare Conference in New York, with a planned slot on September 15, 2026 from 3:10 p.m. to 3:40 p.m. Eastern Time.

The appearance at this investor-focused conference gives management an opportunity to update the market on demand for Invisalign clear aligners, adoption of iTero intraoral scanners and exocad software, and any refinements to guidance that could influence the valuation gap highlighted by recent GF Value analysis.

For shareholders, the conference date serves as the next visible checkpoint in September 2026, coming shortly after the price pullback and against the backdrop of a consensus price target that stands more than USD 50 above the current quotation.

Stock level and risk perspective

Technical commentary from StockTradersDaily on September 9, 2026 points to a current signal price of USD 153.07 for Align Technology, with near-term support and resistance signals around USD 154.32 and USD 158.59, respectively.

The same quantitative framework notes that a breakdown is underway with elevated downside risk if support levels fail, while long-term resistance signals are identified near USD 181.87 and USD 203.96, broadly in line with the 52-week high of just over USD 200.

In practical terms, the stock is trading around USD 153.52 on Nasdaq as of September 8, 2026, roughly USD 47 below the 52-week high of USD 200.44 and more than USD 50 below the consensus price target of USD 206.36, a spread that quant-focused investors and fundamental analysts alike will monitor as Align Technology approaches its next investor presentations.

Align Technology stock price snapshot

At the most recent completed session on September 8, 2026, Align Technology stock closed at USD 153.52 on the Nasdaq, within a 52-week corridor from USD 122.00 to USD 200.44 and implying a market capitalization of about USD 11.0 billion based on MarketBeat data.

Align Technology stock at a glance

  • Company: Align Technology, Inc.
  • ISIN: US0162551016
  • Ticker: ALGN
  • Trading venue: Nasdaq
  • Price (as of September 8, 2026): 153.52 USD
  • Market capitalization: 10.99 billion USD (as of September 9, 2026)
  • Sector / Industry: Health Care / Medical Devices
  • Index membership: S&P 500
  • Next earnings date: September 15, 2026

More news and analyses on Align Technology stock

Disclaimer...

en | US0162551016 | ALIGN TECHNOLOGY | boerse | 70077771 | bgmi